SDSébastien Déglise

Sébastien Déglise

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sébastien Déglise has a total of 247 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular and Molecular Changes Underpinning the Formation of Intimal Hyperplasia in a Model of Static Human Saphenous Vein Ex Vivo Culture

    by Shuang Zhao, Celine Deslarzes, Severine Urfer, Jonathan Thevenet, Clémence Bechelli, Martine Lambelet, Sébastien Déglise, Florent Allagnat

  • Open Access

    Short-term carbohydrate supplementation induces protein dilution and promotes vascular regeneration via the FGF21-adiponectin axis

    by Clémence Bechelli, Diane Macabrey, Michael Robert MacArthur, Severine Urfer, Martine Lambelet, Sebastien Deglise, Florent Allagnat

    Background Dietary preconditioning with caloric or protein restriction improves resilience to ischemic injury, but restrictive dietary regimens are difficult to implement in clinical practice. Carbohydrate loading is widely used in Enhanced Recovery After Surgery (ERAS) protocols to reduce perioperative metabolic stress, yet whether it can activate regenerative pathways associated with dietary protein restriction remains unknown. Methods Male C57BL6/J mice received a sucrose-rich drinking supplement for 5 days before hindlimb ischemia. Vascular repair, tissue injury and metabolic adaptation were assessed by histological, functional, molecular and metabolomic analyses. Genetic loss-of-function models and endothelial cell assays were used to investigate underlying mechanisms. Findings Short-term sucrose supplementation induced voluntary protein dilution despite increased caloric intake and reproduced key metabolic features of dietary protein restriction. This intervention activated hepatic nutrient-sensing pathways, increased circulating FGF21 and adiponectin levels, and improved glucose and lipid metabolism. Dietary preconditioning enhanced endothelial proliferation, angiogenesis and recovery following hindlimb ischemia. These benefits were abolished in Fgf21-deficient mice. Mechanistically, adiponectin promoted endothelial cell proliferation, migration and sprouting angiogenesis through PPARα-dependent metabolic adaptation. Interpretation Short-term carbohydrate supplementation is sufficient to engage a protein-restriction-like regenerative program without caloric restriction and enhances recovery from ischemic injury. These findings provide a mechanistic basis for carbohydrate-loading strategies and support dietary macronutrient manipulation as a practical approach to improve tissue resilience and vascular repair.

  • Open Access

    Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort Study

    by Matthieu Halfon, Raffaella Emsley, Thomas Agius, Arnaud Lyon, Sébastien Déglise, Manuel Pascual, Korkut Uygun, Heidi Yeh, Leonardo V. Riella, James F. Markmann, et al.

    Background.: Hydrogen sulfide (H2S) produced endogenously by the CTH gene-encoded cystathionine gamma-lyase protects from renal ischemia–reperfusion injury in preclinical models. Here, we hypothesized that CTH gene polymorphisms (single nucleotide polymorphism [SNP]) and recipient H2S serum levels influence kidney graft outcomes after transplantation. Methods.: We included all consecutive recipients of a first kidney transplant in the Swiss Transplant Cohort Study and with available genotyping. In addition, 192 deceased-donor kidney transplant recipients were randomly selected to measure baseline serum H2S levels. The primary endpoint was graft loss during follow-up. Results.: CTH SNPs were identified in up to 50% of the patients. During median follow-up (6.4 y, interquartile range: 3.9–9.8), graft loss was observed in 247 (9.8%) of 2518 patients. The incidence of graft loss was associated with the presence or absence of CTH SNPs. Specifically, rs672203 and rs10458561, increased the risk of graft loss (hazard ratio [HR]: 1.36, 95% confidence interval [CI]: 1.04-1.78, P = 0.02; and HR: 1.29, 95% CI: 1.0-1.66, P = 0.05; respectively), whereas rs113285275 was protective (HR: 0.78, 95% CI: 0.6-1.01, P = 0.05). Interestingly, rs672203 was associated with an increased risk of acute rejection (P = 0.05), whereas rs113285275 was associated with a lower risk of acute rejection (P = 0.01). Finally, in patients with delayed graft function, serum H2S levels correlated with lower graft dysfunction (defined as estimated glomerular filtration rate 2) (P = 0.05). Conclusions.: Graft outcome after kidney transplantation was associated with CTH genotype and, to some extent, H2S serum levels. Further research is needed to define the underlying protective mechanisms.

  • Open Access

    Optimizing Photobiomodulation Radiometric and Spectral Parameters In Vitro to Enhance Angiogenesis and Mitochondrial Function

    by Jaroslava Joniová, Aurélien Gregor, Martine Lambelet, Sébastien Déglise, Florent Allagnat, Georges Wagnières

    Photobiomodulation (PBM) therapy, a therapeutic approach utilizing low-level light, has garnered significant attention for its potential to modulate various biological processes. This study aimed at optimizing and investigating the effects of PBM on angiogenesis and mitochondrial metabolic activity. In vitro experiments using human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) were performed to assess PBM’s impacts on cell migration, proliferation, endogenous protoporphyrin IX production, mitochondrial membrane potential, Rhodamine 123 fluorescence lifetime, mitochondrial morphology, and oxygen consumption. Our findings demonstrated that the PBM approach significantly stimulates HUVECs and VSMCs, highlighting the importance of precise light dosimetry for optimal outcomes. Interestingly, our results indicate that in our conditions, the optimal radiometric and spectral parameters are similar for HUVECs and VSMCs for the different endpoints mentioned above. In conclusion, our study strongly suggests that PBM holds promise as a therapeutic intervention for conditions characterized by impaired angiogenesis, such as wound healing, ischemia, and cardiovascular disease. Further research is necessary to fully elucidate the underlying mechanisms and optimize the radiometric and spectral parameters for clinical applications.


  • Top Cited Papers

    2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

    by Lucia Mazzolai, Gisela Teixido-Tura, Stefano Lanzi, Vinko Boc, Eduardo Bossone, Marianne Brodmann, Alessandra Bura-Rivière, Julie De Backer, Sebastien Deglise, Alessandro Della Corte, et al.


  • Open Access

    Unlocking Arteria Lusoria Challenges: Sternotomy's Role in a Single-Stage Aneurysm Repair and Artery Realignment.

    by Ziyad Gunga, Lorene Rousseau, Zied Ltaief, Valentina Rancati, Sébastien Déglise, Matthias Kirsch

    This study presents a case report demonstrating an anomalous origin of the right subclavian artery from the aortic arch, accompanied by proximal dilation and a retro-esophageal course, characteristic of arteria lusoria and Kommerell's diverticulum. The research highlights the clinical significance of this anomaly and discusses its management strategies, emphasizing the importance of precise surgical intervention in addressing this condition.

  • Open Access

    Cystathionine Gamma Lyase Is Regulated by Flow and Controls Smooth Muscle Migration in Human Saphenous Vein

    by Shuang Zhao, Céline Deslarzes-Dubuis, Severine Urfer, Martine Lambelet, Sébastien Déglise, Florent Allagnat

    The saphenous vein is the conduit of choice for bypass grafting. Unfortunately, the hemodynamic stress associated with the arterial environment of the bypass vein graft leads to the development of intimal hyperplasia (IH), an excessive cellular growth and collagen deposition that results in restenosis and secondary graft occlusion. Hydrogen sulfide (H2S) is a ubiquitous redox-modifying gasotransmitter that inhibits IH. H2S is produced via the reverse trans-sulfuration pathway by three enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST). However, the expression and regulation of these enzymes in the human vasculature remains unclear. Here, we investigated the expression of CSE, CBS and 3-MST in segments of native human saphenous vein and large arteries. Furthermore, we evaluated the regulation of these enzymes in vein segments cultured under static, venous (7 mmHg pressure) or arterial (100 mmHg pressure) pressure. CSE was expressed in the media, neointima and intima of the vessels and was negatively regulated by arterial shear stress. Adenoviral-mediated CSE overexpression or RNA interference-mediated CSE knock-down revealed that CSE inhibited primary human VSMC migration but not proliferation. We propose that high shear stress in arteriovenous bypass grafts inhibits CSE expression in both the media and endothelium, which may contribute to increased VSMC migration in the context of IH.


  • Open Access

    Cystathionine gamma lyase is regulated by flow and controls smooth muscle migration in human saphenous vein

    by Shuang Zhao, Céline Deslarzes-Dubuis, Severine Urfer, Martine Lambelet, Sébastien Déglise, Florent Allagnat

    The saphenous vein is the conduit of choice for bypass grafting. Unfortunately, the hemodynamic stress associated with the arterial environment of the bypass vein graft leads to the development of intimal hyperplasia (IH), an excessive cellular growth and collagen deposition that results in restenosis and secondary graft occlusion. Hydrogen sulfide (H2S) is a ubiquitous redox-modifying gasotransmitter that inhibits IH. H2S is produced via the reverse trans-sulfuration pathway by 3 enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST). However, the expression and regulation of these enzymes in the human vasculature remains unclear. Here, we investigated the expression of CSE, CBS and 3-MST in segments of native human saphenous vein and large arteries. Furthermore, we evaluated the regulation of these enzymes in vein segments cultured under static, venous (7 mmHg pressure) or arterial (100 mmHg pressure) pressure. CSE was expressed in the media, neointima and intima of the vessels and was negatively regulated by arterial shear stress. Adenoviral-mediated CSE overexpression or RNA interference-mediated CSE knock-down revealed that CSE inhibited primary human VSMC migration but not proliferation. We propose that high shear stress in arteriovenous bypass grafts inhibits CSE expression in both the media and endothelium, which may contribute to increased VSMC migration in the context of IH.


  • Open Access

    Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease

    by Clémence Bechelli, Diane Macabrey, Sebastien Deglise, Florent Allagnat

    Peripheral artery disease (PAD) affects more than 230 million people worldwide. PAD patients suffer from reduced quality of life and are at increased risk of vascular complications and all-cause mortality. Despite its prevalence, impact on quality of life and poor long-term clinical outcomes, PAD remains underdiagnosed and undertreated compared to myocardial infarction and stroke. PAD is due to a combination of macrovascular atherosclerosis and calcification, combined with microvascular rarefaction, leading to chronic peripheral ischemia. Novel therapies are needed to address the increasing incidence of PAD and its difficult long-term pharmacological and surgical management. The cysteine-derived gasotransmitter hydrogen sulfide (H2S) has interesting vasorelaxant, cytoprotective, antioxidant and anti-inflammatory properties. In this review, we describe the current understanding of PAD pathophysiology and the remarkable benefits of H2S against atherosclerosis, inflammation, vascular calcification, and other vasculo-protective effects.